Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

CERT

Certara Inc

Dec 13 • 04:00PM ET

11.47

Dollar change -0.24
Percentage change -2.05	%

Healthcare • Health Information Services • USA • NASD

Peers: IQV CRL ICLR CERS MEDP QDEL PDCO HCM XERS

| Held by: IJR VTI VB VXF VBK DFAT SPSM IJT SCHA IJS

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.19	Insider Own	30.84%	Shs Outstand	160.90M	Perf Week	5.71%
Market Cap	1.81B	Forward P/E	22.80	EPS next Y	0.50	Insider Trans	-0.12%	Shs Float	111.34M	Perf Month	7.10%
Income	-31.08M	PEG	-	EPS next Q	0.12	Inst Own	66.75%	Short Float	4.45%	Perf Quarter	7.20%
Sales	372.80M	P/S	4.85	EPS this Y	-0.98%	Inst Trans	-3.54%	Short Ratio	3.96	Perf Half Y	-22.97%
Book/sh	6.55	P/B	1.75	EPS next Y	18.15%	ROA	-2.02%	Short Interest	4.95M	Perf Year	-30.40%
Cash/sh	1.48	P/C	7.76	EPS next 5Y	10.53%	ROE	-2.95%	52W Range	9.41 - 19.87	Perf YTD	-34.79%
Dividend Est.	-	P/FCF	34.55	EPS past 5Y	-10.50%	ROI	-2.29%	52W High	-42.28%	Beta	1.52
Dividend TTM	-	Quick Ratio	2.86	Sales past 5Y	16.90%	Gross Margin	45.80%	52W Low	21.89%	ATR (14)	0.50
Dividend Ex-Date	-	Current Ratio	2.86	EPS Y/Y TTM	8.04%	Oper. Margin	0.36%	RSI (14)	57.39	Volatility	5.23% 4.52%
Employees	1391	Debt/Eq	0.30	Sales Y/Y TTM	5.62%	Profit Margin	-8.34%	Recom	2.09	Target Price	14.06
Option/Short	Yes / Yes	LT Debt/Eq	0.29	EPS Q/Q	97.24%	Payout	-	Rel Volume	1.46	Prev Close	11.71
Sales Surprise	-0.72%	EPS Surprise	20.59%	Sales Q/Q	10.80%	Earnings	Nov 06 AMC	Avg Volume	1.25M	Price	11.47
SMA20	5.92%	SMA50	5.80%	SMA200	-18.71%	Trades		Volume	1,828,639	Change	-2.05%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-27-24	Upgrade	UBS	Neutral → Buy	$16
Apr-10-24	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight	$23
Apr-04-24	Initiated	JMP Securities	Mkt Perform
Feb-26-24	Initiated	Leerink Partners	Market Perform	$19
Dec-07-23	Initiated	UBS	Neutral	$17
Dec-05-23	Initiated	KeyBanc Capital Markets	Sector Weight
Aug-22-23	Downgrade	Jefferies	Buy → Hold	$24.50 → $17
Aug-10-23	Downgrade	William Blair	Outperform → Mkt Perform
Apr-12-23	Initiated	Stephens	Overweight	$28
Apr-03-23	Downgrade	Barclays	Overweight → Equal Weight	$25
Dec-14-22	Downgrade	Robert W. Baird	Outperform → Neutral	$17 → $19
Sep-08-22	Initiated	Berenberg	Buy	$23
Aug-25-22	Initiated	Credit Suisse	Outperform	$22
Jul-01-22	Initiated	Piper Sandler	Overweight	$28
Jan-11-22	Upgrade	Jefferies	Hold → Buy	$31
Aug-05-21	Resumed	Credit Suisse	Neutral	$36
Jul-23-21	Initiated	Robert W. Baird	Outperform	$30
Mar-03-21	Initiated	Barclays	Overweight	$40
Jan-06-21	Initiated	Morgan Stanley	Equal-Weight	$35
Jan-05-21	Initiated	William Blair	Outperform

Show Previous Ratings

Dec-06-24 10:02AM	Cautious Spending By Large Biopharma Client Dragged Certara (CERT) in Q3 (Insider Monkey)
Dec-02-24 04:15PM	Certara Showcases 2024 Research Wins With Over 100 Papers Published (GlobeNewswire)
Nov-13-24 09:29AM	Soft Biotech Funding and Cost-Cutting Dragged Certara (CERT) in Q3 (Insider Monkey)
Nov-07-24 10:38AM	Q3 2024 Certara Inc Earnings Call (Thomson Reuters StreetEvents)
02:27AM	Certara Inc (CERT) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
07:05PM	Loading…
Nov-06-24 07:05PM	Certara, Inc. (CERT) Q3 Earnings Surpass Estimates (Zacks) +5.82%
04:15PM	Certara Reports Third Quarter 2024 Financial Results (GlobeNewswire)
Oct-28-24 04:15PM	Certara to Participate in the Stephens Annual Investment Conference (GlobeNewswire)
Oct-16-24 04:15PM	Certara Appoints John Reynders as New Independent Board Member (GlobeNewswire)
Oct-15-24 08:05AM	MaxCyte Appoints Cynthia Collins to its Board of Directors (GlobeNewswire)
Oct-09-24 04:15PM	Certara to Report Third Quarter 2024 Financial Results on November 6th, 2024 (GlobeNewswire)
Oct-02-24 04:15PM	Certara Completes Acquisition of Chemaxon (GlobeNewswire)
Sep-27-24 07:20PM	Final Trade: Certara, Nextera Energy, Knight-Swift Transportation and Lululemon (CNBC TV) +9.81%
Sep-24-24 08:00AM	Certara's Simcyp Consortium Celebrates 25th Anniversary (GlobeNewswire)
Sep-18-24 08:00AM	Certara & Ichnos Glenmark Innovation Collaboration Optimizes Dosing Strategy for Potential First-In-Class Cancer Drug (GlobeNewswire)
11:02AM	Loading…
Sep-17-24 11:02AM	Should You Increase Your Holdings in Certara (CERT)? (Insider Monkey)
Aug-28-24 07:03PM	Certara, Inc. (CERT): Among The Best Medical AI Companies (Insider Monkey) -5.24%
Aug-21-24 04:15PM	Certara to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-15-24 04:15PM	Certara Launches Phoenix Version 8.5 Drug Development Software (GlobeNewswire)
Aug-12-24 03:57AM	Heres Why Certara (CERT) Stock Underperformed in Q2 (Insider Monkey)
Aug-07-24 12:25PM	Q2 2024 Certara Inc Earnings Call (Thomson Reuters StreetEvents) -13.59%
Aug-06-24 06:25PM	Certara, Inc. (CERT) Q2 Earnings and Revenues Lag Estimates (Zacks)
04:15PM	Certara Reports Second Quarter 2024 Financial Results (GlobeNewswire)
Jul-09-24 04:45PM	Certara to Acquire Chemaxon to Strengthen Drug Discovery Software Portfolio (GlobeNewswire)
Jul-02-24 04:15PM	Certara to Report Second Quarter 2024 Financial Results on August 6th, 2024 (GlobeNewswire)
Jun-17-24 08:00AM	Certara Launches Next Generation CoAuthor Generative AI Regulatory Writing Software (GlobeNewswire)
May-29-24 04:15PM	Certara to Participate in the Jefferies Global Healthcare Conference (GlobeNewswire)
May-21-24 08:00AM	Certara Appoints New Chief Human Resources Officer & General Counsel (GlobeNewswire)
May-09-24 02:45PM	Certara, Inc. (NASDAQ:CERT) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-08-24 01:16PM	Q1 2024 Certara Inc Earnings Call (Thomson Reuters StreetEvents) -7.42%
05:48AM	Loading…
05:48AM	Certara Q1 Adjusted Earnings Down, Revenue Increases (MT Newswires)
04:13AM	Certara Inc (CERT) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges and ... (GuruFocus.com)
May-07-24 06:40PM	Certara, Inc. (CERT) Q1 Earnings Meet Estimates (Zacks)
05:59PM	Certara Inc (CERT) Q1 2024 Earnings: Mixed Results Amidst Revenue Growth and Net Loss (GuruFocus.com)
04:15PM	Certara Reports First Quarter 2024 Financial Results (GlobeNewswire)
May-06-24 03:19AM	What Makes Certara (CERT) an Attractive Bet? (Insider Monkey)
Apr-16-24 08:00AM	Certara Launches Cloud Platform to Further Unify its End-to-End Scientific Software Platform (GlobeNewswire)
Apr-09-24 04:15PM	Certara to Report First Quarter 2024 Financial Results on May 7th, 2024 and Participate in the BofA Securities Healthcare Conference (GlobeNewswire)
Apr-04-24 07:01PM	Insider Sell: President of Drug Dev Solutions at Certara Inc (CERT) Sells Shares (GuruFocus.com) +5.15%
Mar-02-24 08:41AM	Certara, Inc. (NASDAQ:CERT) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-01-24 07:10AM	Q4 2023 Certara Inc Earnings Call (Thomson Reuters StreetEvents) +8.41%
Feb-29-24 06:05PM	Certara, Inc. (CERT) Lags Q4 Earnings Estimates (Zacks)
04:52PM	Certara Inc (CERT) Reports Modest Revenue Growth Amidst Net Loss in Q4 2023 (GuruFocus.com)
04:10PM	Certara Reports Fourth Quarter 2023 Financial Results (GlobeNewswire)
Feb-01-24 04:30PM	Certara to Report Fourth Quarter and Full Year 2023 Financial Results on February 29th, 2024 and Participate in the Barclays 26th Annual Global Healthcare Conference (GlobeNewswire)
Jan-31-24 11:03PM	Baillie Gifford Adjusts Position in Certara Inc (GuruFocus.com)
Dec-13-23 04:30PM	Certara Acquires Applied BioMath Expanding Its Biosimulation Portfolio to Industrialize New Capabilities for Optimal Dosing for Novel Therapies (GlobeNewswire)
Nov-21-23 04:30PM	Certara introduces Simcyp Biopharmaceutics software to increase efficiency of novel and generic drug formulation & development (GlobeNewswire)
Nov-10-23 01:22PM	Certara, Inc. (NASDAQ:CERT) Q3 2023 Earnings Call Transcript (Insider Monkey) +6.72%
Nov-09-23 10:41AM	Q3 2023 Certara Inc Earnings Call (Thomson Reuters StreetEvents)
Nov-08-23 07:15PM	Certara, Inc. (CERT) Q3 Earnings Meet Estimates (Zacks)
04:10PM	Certara Reports Third Quarter 2023 Financial Results (GlobeNewswire)
Oct-31-23 12:00PM	Top 12 Medical AI Companies (Insider Monkey)
Oct-20-23 08:34AM	Are Options Traders Betting on a Big Move in Certara (CERT) Stock? (Zacks)
Oct-11-23 04:15PM	Certara to Report Third Quarter 2023 Financial Results on November 8th, 2023, and participate in the Stephens Annual Investment Conference (GlobeNewswire)
Sep-19-23 08:15AM	Certara Announces 300th Regulatory Submission Milestone Using its Technology-enabled Services and Software (GlobeNewswire)
Sep-13-23 05:01AM	Insider Sell: Leif Pedersen Sells 51,224 Shares of Certara Inc (CERT) (GuruFocus.com)
Aug-29-23 04:15PM	Certara to Participate in Upcoming Investor Conferences (GlobeNewswire)
08:15AM	Certara Simcyp Group Awarded Two New Grants from US FDA (GlobeNewswire)
Aug-23-23 01:43PM	Analysts on Wall Street Lower Ratings for These 10 Stocks (Insider Monkey)
Aug-22-23 02:41AM	4 big analyst cuts: Target slashed to Neutral after Q2 Earnings (Investing.com)
Aug-12-23 08:07AM	Certara, Inc. (NASDAQ:CERT) Consensus Forecasts Have Become A Little Darker Since Its Latest Report (Simply Wall St.)
Aug-11-23 06:09AM	Certara Second Quarter 2023 Earnings: Revenues Disappoint (Simply Wall St.)
Aug-10-23 09:41AM	Q2 2023 Certara Inc Earnings Call (Thomson Reuters StreetEvents) -7.65%
Aug-09-23 04:15PM	Certara Reports Second Quarter 2023 Financial Results (GlobeNewswire)
Aug-03-23 09:00PM	Certara collaborates with Korea Institute of Toxicology to ensure FDA submission-ready SEND dataset (Business Wire)
Aug-02-23 08:55AM	There's Been No Shortage Of Growth Recently For Certara's (NASDAQ:CERT) Returns On Capital (Simply Wall St.)
Jul-27-23 09:47AM	12 Best Growth Stocks Under $25 (Insider Monkey)
Jul-13-23 04:30PM	Certara to Report Second Quarter 2023 Financial Results on August 9th, 2023 (GlobeNewswire)
Jun-02-23 04:15PM	Certara to Participate in the Jefferies Global Healthcare Conference (GlobeNewswire)
May-16-23 06:50AM	Reasons to Invest in Certara (CERT) (Insider Monkey)
May-09-23 06:53AM	Q1 2023 Certara Inc Earnings Call (Thomson Reuters StreetEvents) -10.72%
May-08-23 06:35PM	Certara, Inc. (CERT) Matches Q1 Earnings Estimates (Zacks)
04:15PM	Certara Reports First Quarter 2023 Financial Results (GlobeNewswire)
May-02-23 10:02AM	Guardant Health (GH) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
04:24AM	Factors to Note Ahead of Atlassian's (TEAM) Q3 Earnings Release (Zacks)
May-01-23 02:03PM	DraftKings (DKNG) to Report Q1 Earnings: What's in Store? (Zacks)
10:01AM	Certara, Inc. (CERT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
07:13AM	The Zacks Analyst Blog Highlights Shake Shack, Wingstop, AssetMark Financial, Primerica and Certara (Zacks)
Apr-28-23 07:15AM	5 Must-Buy High-Flying Mid-Cap Stocks Ahead of Q1 Earnings (Zacks)
Apr-27-23 08:00AM	Certara Customers Received 90 Percent of US FDA Novel Drug Approvals for 9th Consecutive Year (GlobeNewswire)
Apr-10-23 04:30PM	Certara to Report First Quarter 2023 Financial Results on May 8th, 2023 and Participate in the BofA Securities 2023 Healthcare Conference (GlobeNewswire)
Apr-06-23 12:19PM	MorphoSys Up on Finishing Early Enrolment in Myelofibrosis Study (Zacks)
Apr-05-23 12:25PM	AstraZeneca's (AZN) Drug Combo Meets Ovarian Cancer Study Goal (Zacks)
11:42AM	VBI Vaccines (VBIV) Down 53% on Initiating Restructuring Plans (Zacks)
Apr-04-23 12:43PM	Ascendis (ASND) Down on Hypoparathyroidism Drug NDA Deficiencies (Zacks)
Mar-29-23 12:01PM	Biomea (BMEA) Up 99% on Upbeat Data From Type II Diabetes Study (Zacks)
Mar-28-23 03:00PM	GSK's Jemperli Effective Against First-Line Endometrial Cancer (Zacks)
Mar-27-23 11:35AM	Iovance (IOVA) Completes Rolling BLA Filing for Melanoma Drug (Zacks)
Mar-15-23 05:41PM	Exponent Set to Join S&P MidCap 400; CVR Energy and Certara to Join S&P SmallCap 600 (PR Newswire) +10.80%
10:00AM	Best Momentum Stocks to Buy for March 15th (Zacks)
Mar-14-23 09:40AM	Is Certara (CERT) Outperforming Other Medical Stocks This Year? (Zacks)
Mar-09-23 12:20PM	Can Certara, Inc. (CERT) Run Higher on Rising Earnings Estimates? (Zacks)
08:00AM	A.I. Coming to Certaras D360 Scientific Informatics Software (GlobeNewswire)
Mar-08-23 07:04AM	Certara, Inc. (NASDAQ:CERT) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-07-23 08:00AM	Certara announces the release of Simcyp PBPK Simulator Version 22, expanding ability to simulate untested scenarios for new patient and therapeutic types (GlobeNewswire)
Mar-02-23 07:43AM	Q4 2022 Certara Inc Earnings Call (Thomson Reuters StreetEvents) +17.30%
Mar-01-23 06:25PM	Certara, Inc. (CERT) Tops Q4 Earnings and Revenue Estimates (Zacks)
04:16PM	Certara Reports Fourth Quarter and Full Year 2022 Financial Results (GlobeNewswire)
04:15PM	Certara Announces Transition Plan for Chief Financial Officer (GlobeNewswire)

Certara, Inc. engages in the provision of software and technology-enabled services for drug developers. It offers cell and gene therapy, clinical pharmacology, complex biologics, decision analytics and modeling, drug development and regulatory strategy, and model-based analysis services. The company was founded on June 27, 2017, and is headquartered in Radnor, PA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
SMITH PATRICK F	PRESIDENT, DRUG DEV SOLUTIONS	Oct 07 '24	Sale	11.03	5,409	59,661	50,091	Oct 08 04:17 PM
SMITH PATRICK F	PRESIDENT, DRUG DEV SOLUTIONS	Oct 04 '24	Option Exercise	0.00	7,151	0	57,242	Oct 07 04:42 PM
SMITH PATRICK F	Officer	Oct 07 '24	Proposed Sale	11.03	5,409	59,661		Oct 07 09:48 AM
Pedersen Leif E	PRESIDENT, CHIEF COMMERCAL OFF	Sep 09 '24	Sale	11.29	51,224	578,319	99,704	Sep 10 05:01 PM
Pedersen Leif E	Officer	Sep 09 '24	Proposed Sale	11.29	51,224	578,450		Sep 09 04:27 PM
WALSH MATTHEW M	Director	May 21 '24	Option Exercise	0.00	8,663	0	185,631	May 23 04:45 PM
Killefer Nancy	Director	May 21 '24	Option Exercise	0.00	8,663	0	24,161	May 23 04:40 PM
Crane Rosemary A	Director	May 21 '24	Option Exercise	0.00	8,663	0	17,987	May 23 04:35 PM
Collins Cynthia	Director	May 21 '24	Option Exercise	0.00	8,663	0	24,161	May 23 04:29 PM
CASHMAN JAMES E III	Chairman	May 21 '24	Option Exercise	0.00	8,663	0	456,512	May 23 04:22 PM
BROSHY ERAN	Director	May 21 '24	Option Exercise	0.00	8,663	0	23,023	May 23 04:17 PM
SMITH PATRICK F	PRESIDENT, DRUG DEV SOLUTIONS	Apr 02 '24	Sale	16.85	14,427	243,161	50,091	Apr 04 04:45 PM
Traynor Richard M.	SVP AND GENERAL COUNSEL	Apr 01 '24	Option Exercise	0.00	13,295	0	178,800	Apr 03 05:08 PM
Traynor Richard M.	SVP AND GENERAL COUNSEL	Apr 01 '24	Sale	18.00	3,000	54,000	173,524	Apr 03 05:08 PM
SMITH PATRICK F	PRESIDENT, DRUG DEV SOLUTIONS	Apr 01 '24	Option Exercise	0.00	16,498	0	67,208	Apr 03 05:07 PM
SHERMAN NICOLETTE D	CHIEF HUMAN RESOURCES OFFICER	Apr 01 '24	Option Exercise	0.00	8,219	0	25,684	Apr 03 05:05 PM
Pedersen Leif E	PRESIDENT, CHIEF COMMERCAL OFF	Apr 01 '24	Option Exercise	0.00	16,498	0	152,840	Apr 03 05:03 PM
Gallagher John E	CHIEF FINANCIAL OFFICER	Apr 01 '24	Option Exercise	0.00	27,295	0	22,545	Apr 03 05:02 PM
Aspbury Robert	PRESIDENT; SCIENTIFIC SOFTWARE	Apr 01 '24	Option Exercise	0.00	16,498	0	293,867	Apr 03 05:00 PM
Feehery William F	CHIEF EXECUTIVE OFFICER	Apr 01 '24	Option Exercise	0.00	69,799	0	2,263,269	Apr 03 04:44 PM
Traynor Richard M.	SVP AND GENERAL COUNSEL	Mar 04 '24	Sale	18.28	3,000	54,840	162,368	Mar 05 04:45 PM
SMITH PATRICK F	PRESIDENT, DRUG DEV SOLUTIONS	Feb 20 '24	Sale	18.00	5,000	90,000	54,975	Feb 21 04:40 PM
Traynor Richard M.	SVP AND GENERAL COUNSEL	Feb 12 '24	Sale	18.00	6,000	108,000	165,368	Feb 14 04:33 PM
Traynor Richard M.	SVP AND GENERAL COUNSEL	Dec 26 '23	Sale	18.00	6,000	108,000	171,368	Dec 27 06:36 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CERT

Certara Inc

Upgrade your FINVIZ experience